Srinivas K. Tantravahi

Dr. Srinivas K. Tantravahi is a Clinical Associate Professor in the Department of Internal Medicine at the University of Utah School of Medicine, affiliated with the Huntsman Cancer Institute. Board-certified in Hematology, Medical Oncology, and Medical Council of India, he specializes in hematologic malignancies, including leukemias, myeloproliferative neoplasms, bone marrow failure, and telomere biology disorders.

• Internal Medicine Residency: University of Utah
• Hematology & Oncology Fellowship: University of Utah
• M.B.B.S.: Guntur Medical College

Dr. Tantravahi's research focuses on genetic mechanisms of blood cancers, particularly germline predispositions to bone marrow failure and leukemias. His work bridges clinical trials with translational research, exploring targeted therapies and biomarker-driven treatment strategies for myeloproliferative neoplasms and leukemias.

His publications highlight expertise in CML, MDS, CMML, and myelofibrosis, with emphasis on tyrosine kinase inhibitors, combination therapies, and genomic landscapes. He has contributed to NCCN clinical guidelines and advanced understanding of inflammatory and molecular pathways in hematologic disorders.

Dr. Tantravahi is a member of the American Society of Hematology, Society of Hematologic Oncology, and American Society of Clinical Oncology, driving clinical innovation through multidisciplinary collaboration at the University of Utah and Huntsman Cancer Institute.